Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia.
Bizargity
P
P
Adigüzel
C
C
Ozilhan
G
G
Bayik
M
M
Eksioglu-Demiralp
E
E
D001549:Benzamides; D005434:Flow Cytometry; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D016897:Respiratory Burst / Q000187:drug effects*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate